Sichuan Kelun-Biotech Says NMPA Accepts SAC-TMT New Indication Application
China’s NMPA accepted a new indication application for SAC-TMT, Sichuan Kelun-Biotech Biopharmaceutical says.
Related stories
Reddit Shares Plunge 18% After Revenue Outlook Misses Expectations
Reddit shares fell about 18% in after-hours trading in New York after the company said it would limit unregistered users’ access to its platform and issued a revenue outlook below
M impact | EQUITY | Oct 30, 2026, 01:51 AM UTC
Kingsgate Consolidated Reports Quarterly Gold and Silver Sales
Kingsgate Consolidated reported gold sales of 17,339 ounces and silver sales of 211,081 ounces for the quarter.
M impact | EQUITY | Oct 30, 2026, 01:46 AM UTC
Kingsgate Consolidated Produces 14,802 Ounces of Gold and 187,925 Ounces of Silver
The company reported an all-in sustaining cost of US$1,547 per ounce and said the metals were sold in the quarter.
L impact | EQUITY | Oct 30, 2026, 01:46 AM UTC
China’s Xinyi Sheng Drops 15.1% as Q3 Net Profit Falls
Xinyi Sheng shares fell as much as 15.1% Friday morning after its third-quarter net profit declined nearly one-fifth quarter over quarter.
M impact | EQUITY | Oct 30, 2026, 01:45 AM UTC
Mastercard Shares Rise More Than 4% After Q3 Results Beat Expectations
Mastercard shares gained more than 4% at Thursday’s close, reached a 52-week high of $641.56 during regular trading and logged their best session since January.
M impact | EQUITY | Oct 30, 2026, 01:45 AM UTC
Hyundai Glovis Q3 Operating Profit Rises 8.1%
Hyundai Glovis reported an 8.1% year-on-year rise in third-quarter operating profit.
M impact | EQUITY | Oct 30, 2026, 01:45 AM UTC